EAMA
ABBV icon

EFG Asset Management (Americas)’s AbbVie ABBV Stock Holding History

EFG Asset Management (Americas)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.3M Sell
9,919
-722
-7% -$147K 0.4% 82
2025
Q2 		$1.98M Sell
10,641
-1,116
-9% -$207K 0.36% 80
2025
Q1 		$2.46M Sell
11,757
-78
-0.7% -$15.2K 0.5% 60
2024
Q4 		$2.1M Buy
11,835
+1,640
+16% +$302K 0.41% 79
2024
Q3 		$2.01M Sell
10,195
-589
-5% -$110K 0.39% 75
2024
Q2 		$1.85M Buy
10,784
+2,783
+35% +$461K 0.36% 78
2024
Q1 		$1.46M Sell
8,001
-2,001
-20% -$345K 0.44% 67
2023
Q4 		$1.55M Sell
10,002
-31
-0.3% -$4.52K 0.33% 86
2023
Q3 		$1.5M Sell
10,033
-198
-2% -$29.1K 0.36% 82
2023
Q2 		$1.38M Buy
10,231
+2,683
+36% +$393K 0.32% 86
2023
Q1 		$1.2M Buy
7,548
+528
+8% +$80.7K 0.29% 89
2022
Q4 		$1.13M Buy
7,020
+371
+6% +$56.9K 0.28% 91
2022
Q3 		$892K Sell
6,649
-235
-3% -$33.7K 0.23% 96
2022
Q2 		$1.05M Buy
6,884
+1,024
+17% +$156K 0.25% 87
2022
Q1 		$950K Sell
5,860
-23
-0.4% -$3.34K 0.18% 94
2021
Q4 		$797K Sell
5,883
-774
-12% -$91.4K 0.13% 97
2021
Q3 		$718K Buy
6,657
+297
+5% +$33.9K 0.13% 102
2021
Q2 		$716K Buy
6,360
+256
+4% +$28.8K 0.13% 104
2021
Q1 		$661K Buy
+6,104
New +$653K 0.14% 106
2015
Q1 		– Sell
-220
Closed -$14K – 149
2014
Q4 		$14K Buy
+220
New +$13.9K 0.01% 184

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EFG Asset Management (Americas)'s ABBV Position: Q3 2025 in Review

EFG Asset Management (Americas) reduced its AbbVie (ABBV) stake by 6.8% in Q3 2025, selling an estimated $147K and leaving 9,919 shares worth $2.3M. The position accounts for 0.4% of the portfolio, ranked #82.

EFG Asset Management (Americas) first reported a position in ABBV in Q4 2014 and has held it in 20 quarters since. The position peaked at $2.46M in Q1 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • EFG Asset Management (Americas) held 9,919 shares of AbbVie worth $2.3M as of Q3 2025.
  • EFG Asset Management (Americas) sold 722 AbbVie shares in Q3 2025, an estimated $147K.
  • AbbVie made up 0.4% of EFG Asset Management (Americas)'s portfolio in Q3 2025, its #82 holding.
  • EFG Asset Management (Americas) first reported a position in AbbVie in Q4 2014 and has held it in 20 quarters since.
  • EFG Asset Management (Americas)'s AbbVie position peaked at $2.46M in Q1 2025.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on EFG Asset Management (Americas)'s 13F filing for Q3 2025, filed 14 Nov 2025.